Financial reports
10-Q
2024 Q1
Quarterly report
9 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
Current reports
8-K
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
9 May 24
8-K
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
14 Mar 24
8-K
IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
11 Dec 23
8-K
Other Events
11 Dec 23
8-K
Departure of Directors or Certain Officers
7 Dec 23
8-K
Other Events
20 Nov 23
8-K
IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9 Nov 23
8-K
Other Events
12 Oct 23
8-K
IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
10 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
16 Jun 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
7 May 24
S-8
Registration of securities for employees
19 Jan 24
424B3
Prospectus supplement
18 Jan 24
S-3
Shelf registration
12 Jan 24
D
$14.43 mm in equity / options, sold $14.43 mm, 20 investors
28 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Aug 23
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Aug 23
S-8
Registration of securities for employees
18 Aug 23
424B5
Prospectus supplement for primary offering
31 Jul 23
424B5
Prospectus supplement for primary offering
14 Jul 23
Other
EFFECT
Notice of effectiveness
19 Jan 24
UPLOAD
Letter from SEC
16 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
EFFECT
Notice of effectiveness
22 Nov 22
UPLOAD
Letter from SEC
17 Nov 22
CORRESP
Correspondence with SEC
17 Nov 22
EFFECT
Notice of effectiveness
12 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
UPLOAD
Letter from SEC
26 Jul 22
Ownership
SC 13G/A
Ho William Tai-Wei
13 Feb 24
4
Corinne Epperly
8 Feb 24
4
William Tai-Wei Ho
8 Feb 24
4
Trishna Goswami
8 Feb 24
4
Kate Rochlin
8 Feb 24
4
Lawrence Lamb
8 Feb 24
4
Patrick McCall
8 Feb 24
SC 13G/A
Transcend Partners Opportunity Fund I LLC
15 Dec 23
4
Jeremy R. Graff
15 Dec 23
4
Corinne Epperly
15 Dec 23